Reduced Efficacy of Anti-Aβ Immunotherapy in a Mouse Model of Amyloid Deposition and Vascular Cognitive Impairment Comorbidity

Vascular cognitive impairment and dementia (VCID) is the second most common form of dementia behind Alzheimer's disease (AD). It is estimated that 40% of AD patients also have some form of VCID. One promising therapeutic for AD is anti-Aβ immunotherapy, which uses antibodies against Aβ to clear...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Neurosci
Autores principales: Weekman, Erica M., Sudduth, Tiffany L., Caverly, Carly N., Kopper, Timothy J., Phillips, Oliver W., Powell, Dave K., Wilcock, Donna M.
Formato: Artigo
Lenguaje:Inglês
Publicado: Society for Neuroscience 2016
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5030351/
https://ncbi.nlm.nih.gov/pubmed/27656027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.1762-16.2016
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares